The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.
In a statement today, however, Merrion said its board had looked at a number of investment proposals, none of which were thought "sufficiently compelling" to recommend to shareholders.
The board said a statutory declaration of solvency for the company indicated that around €4.5m was available to shareholders from the proposed liquidation, though this figure...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team